Skip to content

The Effect of Iyengar Yoga Practice on Patients with Multiple Sclerosis

The Effect of Iyengar Yoga Practice on Patients with Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05247372
Enrollment
5
Registered
2022-02-18
Start date
2021-06-25
Completion date
2022-06-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS

Brief summary

The aim of this work is to find out what effect the practice of Iyengar yoga has on patients with multiple sclerosis on the EDSS 5 and more, specifically in the field of mobility, self-sufficiency and anxiety.

Interventions

OTHERThe effect of Iyengar yoga practice on patients with multiple sclerosis

The study will be conducted as a longitudinal follow-up - at first patients will fbe examined 2 months before the start of the exercise, than they will be examined at the beginning and end of the exercise, which they will attend for 3 months. Patients will be re-examined 2 months after the end of the exercise to clarify the continuing effect of the exercise. The examination will include a basic kinesiological analysis and a neurological examination,TUG test, 6MWT along with the Borg Subjective Weight Rating Scale and T25FWT, BBS, NHPT and stable sitting time in wheelchairs. To evaluate the development of the chest, the respiratory amplitude will be examined and the position of the spine in statics and dynamics will be evaluated using a spinal mouse. Quality of life will be assessed through the MFIS, MSIS-29, MSQOL 54 questionares and Beck's anxiety inventory.

Sponsors

University Hospital, Motol
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age over 18 years * diagnosis of multiple sclerosis * EDSS grade 5 or higher

Exclusion criteria

* age less than 18 years * the patient is not diagnosed with multiple sclerosis EDSS grade less than 5 * refusal of the subject to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Hypothesis 13 monthsIncrease in respiratory amplitud. It will be measured by the meter.
Hypothesis 23 monthsIncrease in spinal development in the sagittal and frontal plane. It will by measured by spinal mouse.
Hypothesis 33 monthsIncrease in walking speed measured by T25FWT. It will by measured by stopwatch.
Hypothesis 43 monthsBalance improvement in the Berg balance scale. It will be measured by the Berg balance scale questionare.
Hypothesis 53 monthsThe quality of life of patients with MS is improved subjectively evaluated through MSQOL54 questionare.

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026